Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Jose Perez Ruixo

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|January 4, 2012
Lifespan based indirect response modelsWojciech Krzyzanski, Juan Jose Perez Ruixo
Pharmaceutical Research|February 24, 2007
An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjectsWojciech Krzyzanski, Juan Jose Perez-Ruixo
Journal of Pharmacokinetics and Pharmacodynamics|September 6, 2015
Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in miceWojciech Krzyzanski, Juan Jose Perez-Ruixo, John Harrold
The AAPS Journal|January 18, 2020
Dose Correction for a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing RegimensXiaoyu Yan, Juan Jose Perez Ruixo, Wojciech Krzyzanski
Journal of Pharmacokinetics and Pharmacodynamics|June 14, 2008
Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cellsWojciech Krzyzanski, Juan Jose Perez-Ruixo, An Vermeulen
The AAPS Journal|November 10, 2012
The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeutic protein pharmacokineticsJuan Jose Perez Ruixo, Peiming Ma, Andrew T Chow
Clinical Pharmacokinetics|January 27, 2007
Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjectsPer Olsson-Gisleskog, Philippe Jacqmin, Juan Jose Perez-Ruixo
Journal of Clinical Pharmacology|February 25, 2015
Quantitative pharmacology of denosumab in patients with bone metastases from solid tumorsJuan Jose Perez Ruixo, Sameer Doshi, Winnie Sohn, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.
Journal of Clinical Pharmacology|April 25, 2015
Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic modelLiviawati Wu, Diane R Mould, Juan Jose Perez Ruixo, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of Pharmacokinetics and Pharmacodynamics|January 4, 2012
Lifespan based indirect response modelsWojciech Krzyzanski, Juan Jose Perez Ruixo
Pharmaceutical Research|February 24, 2007
An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjectsWojciech Krzyzanski, Juan Jose Perez-Ruixo
Journal of Pharmacokinetics and Pharmacodynamics|September 6, 2015
Pharmacodynamic model for chemoradiotherapy-induced thrombocytopenia in miceWojciech Krzyzanski, Juan Jose Perez-Ruixo, John Harrold
The AAPS Journal|January 18, 2020
Dose Correction for a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing RegimensXiaoyu Yan, Juan Jose Perez Ruixo, Wojciech Krzyzanski
Journal of Pharmacokinetics and Pharmacodynamics|June 14, 2008
Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cellsWojciech Krzyzanski, Juan Jose Perez-Ruixo, An Vermeulen
The AAPS Journal|November 10, 2012
The utility of modeling and simulation approaches to evaluate immunogenicity effect on the therapeutic protein pharmacokineticsJuan Jose Perez Ruixo, Peiming Ma, Andrew T Chow
Clinical Pharmacokinetics|January 27, 2007
Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjectsPer Olsson-Gisleskog, Philippe Jacqmin, Juan Jose Perez-Ruixo
Journal of Clinical Pharmacology|February 25, 2015
Quantitative pharmacology of denosumab in patients with bone metastases from solid tumorsJuan Jose Perez Ruixo, Sameer Doshi, Winnie Sohn, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.
Journal of Clinical Pharmacology|April 25, 2015
Assessment of hemoglobin responsiveness to epoetin alfa in patients on hemodialysis using a population pharmacokinetic pharmacodynamic modelLiviawati Wu, Diane R Mould, Juan Jose Perez Ruixo, et al.
Pageof 7